Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.

Source:http://linkedlifedata.com/resource/pubmed/id/19500523

Vaccine 2009 Jul 16 27 33 4412-23

Download in:

View as

General Info

PMID
19500523